Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mijia Lu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
EMBO Reports|March 7, 2023
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in miceAdam D Kenney, Ashley Zani, Jeffrey Kawahara, et al.
Journal of Virology|August 11, 2021
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in HamstersMijia Lu, Yuexiu Zhang, Piyush Dravid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and PathologyMohamed M Shamseldin, Adam Kenney, Ashley Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spikeYuexiu Zhang, Mijia Lu, K C Mahesh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.
Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2022
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosisMostafa M Eltobgy, Ashley Zani, Adam D Kenney, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
EMBO Reports|March 7, 2023
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in miceAdam D Kenney, Ashley Zani, Jeffrey Kawahara, et al.
Journal of Virology|August 11, 2021
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in HamstersMijia Lu, Yuexiu Zhang, Piyush Dravid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and PathologyMohamed M Shamseldin, Adam Kenney, Ashley Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spikeYuexiu Zhang, Mijia Lu, K C Mahesh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.
Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2022
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosisMostafa M Eltobgy, Ashley Zani, Adam D Kenney, et al.
Pageof 3